RAMUCIRUMAB 500 mg/50 mL (Cyramza) Injection

Uses of RAMUCIRUMAB 500 mg

• Treats advanced gastric and gastroesophageal junction (GEJ) cancer
• Treats non-small cell lung cancer (NSCLC)
• Treats hepatocellular carcinoma (liver cancer)
• Treats metastatic colorectal cancer
• Used alone or in combination with other anticancer medicines

Benefits of RAMUCIRUMAB

• Targets cancer cells with precision
• Helps slow tumor growth
• Reduces the formation of new blood vessels that feed tumors
• Supports longer progression-free survival
• Can be combined with other cancer treatments

How Does RAMUCIRUMAB 500 mg Work?

Ramucirumab 500 mg is a monoclonal antibody that blocks the vascular endothelial growth factor receptor-2 (VEGFR-2). By preventing this receptor from being activated, it inhibits the formation of new blood vessels that supply oxygen and nutrients to tumors, helping slow cancer growth and spread.

Side Effects

• High blood pressure
• Fatigue
• Diarrhea
• Headache
• Nosebleeds
• Loss of appetite
• Protein in the urine
• Infusion-related reactions

Precautions

• Administer only under the supervision of an oncologist or trained healthcare professional.
• Regular monitoring of blood pressure, urine protein, and blood tests is recommended.
• Inform your doctor if you have uncontrolled high blood pressure, bleeding disorders, or a history of blood clots.
• Tell your healthcare provider if you have recently had surgery or are planning surgery, as the medicine may delay wound healing.
• Inform your doctor about all medications and supplements you are taking.
• Avoid pregnancy during treatment and use effective contraception as advised.
• Seek immediate medical attention if you experience severe bleeding, chest pain, difficulty breathing, or signs of an allergic reaction.